Home
About
Overview
Sharing Data
ORCID
Help
History (0)
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Search Result Details
Back to Search Results
This page shows the details of why an item matched the keywords from your search.
Search Results
Karrison, Theodore
One or more keywords matched the following items that are connected to
Karrison, Theodore
Item Type
Name
Concept
Vascular Endothelial Growth Factor Receptor-2
Concept
Receptors, Vascular Endothelial Growth Factor
Concept
Vascular Endothelial Growth Factor A
Academic Article
A randomized Phase II trial of the antiangiogenic agent SU5416 in hormone-refractory prostate cancer.
Academic Article
Erlotinib and bevacizumab in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck: a phase I/II study.
Academic Article
Phase II trial of bevacizumab plus gemcitabine in patients with advanced pancreatic cancer.
Academic Article
Ambulatory monitoring detects sorafenib-induced blood pressure elevations on the first day of treatment.
Academic Article
Sorafenib dose escalation is not uniformly associated with blood pressure elevations in normotensive patients with advanced malignancies.
Academic Article
Effects of vascular endothelial growth factor signaling inhibition on human erythropoiesis.
Academic Article
Identification of a variant in KDR associated with serum VEGFR2 and pharmacodynamics of Pazopanib.
Academic Article
Technical considerations in the development of circulating peptides as pharmacodynamic biomarkers for angiogenesis inhibitors.
Academic Article
Serum C-Telopeptide Collagen Crosslinks and Plasma Soluble VEGFR2 as Pharmacodynamic Biomarkers in a Trial of Sequentially Administered Sunitinib and Cilengitide.
Academic Article
A multicenter, open-label, randomized, phase II study of cediranib with or without lenalidomide in iodine 131-refractory differentiated thyroid cancer.
Search Criteria
Vascular Endothelial Growth Factor A